» Authors » George S Charames

George S Charames

Explore the profile of George S Charames including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 512
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Randall Armel S, Malcolmson J, Volenik A, Maganti M, Watkins N, Charames G, et al.
Breast Cancer Res Treat . 2025 Feb; PMID: 39985623
Purpose: Despite guidelines recommending genetic testing for all cases of very young breast cancer (VYBC), poor uptake has been reported. This study aimed to examine genetic testing referral rates and...
2.
Hahn E, Mighton C, Fisher Y, Wong A, Di Gioacchino V, Watkins N, et al.
J Med Genet . 2024 May; 61(8):788-793. PMID: 38806232
Background: Variant classification in the setting of germline genetic testing is necessary for patients and their families to receive proper care. Variants are classified as pathogenic (P), likely pathogenic (LP),...
3.
Panchal S, Mahajan R, Aujla N, McKay P, Casalino S, Di Gioacchino V, et al.
J Med Genet . 2023 Dec; 61(5):477-482. PMID: 38124008
Objective: The purpose of this study was to recontact individuals with clinically actionable test results identified through a retrospective research study and to provide a framework for laboratories to recontact...
4.
Pankiw M, Brezden-Masley C, Charames G
Med Oncol . 2023 Nov; 41(1):1. PMID: 37993657
Considerable advancements in next generation sequencing (NGS) techniques have sparked the use of comprehensive genomic profiling (CGP) as a guiding tool for precision-centered oncological treatments. The past two decades have...
5.
Shrestha M, Blay S, Liang S, Swanson D, Lerner-Ellis J, Dickson B, et al.
J Mol Diagn . 2023 Mar; 25(6):320-330. PMID: 36958423
Next-generation sequencing is a superior method for detecting known and novel RNA fusions in formalin-fixed, paraffin-embedded tissue over fluorescence in situ hybridization and RT-PCR. However, confidence in fusion calling and...
6.
Gajic-Veljanoski O, Li C, Schaink A, Guo J, Shehata N, Charames G, et al.
Transfusion . 2022 Feb; 62(5):1089-1102. PMID: 35170037
Background: We sought to determine the cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies in Canada. Study Design And Methods: We developed two probabilistic state-transition...
7.
Mighton C, Smith A, Mayers J, Tomaszewski R, Taylor S, Hume S, et al.
J Med Genet . 2021 Apr; 59(6):571-578. PMID: 33875564
Background: This study aimed to identify and resolve discordant variant interpretations across clinical molecular genetic laboratories through the Canadian Open Genetics Repository (COGR), an online collaborative effort for variant sharing...
8.
Watkins N, Charames G
J Appl Lab Med . 2021 Feb; 3(2):338-341. PMID: 33636945
No abstract available.
9.
Lerner-Ellis J, Mighton C, Lazaro C, Watkins N, Di Gioacchino V, Wong A, et al.
J Cancer Res Clin Oncol . 2020 Sep; 147(8):2487. PMID: 32975687
No abstract available.
10.
Lerner-Ellis J, Mighton C, Lazaro C, Watkins N, Di Gioacchino V, Wong A, et al.
J Cancer Res Clin Oncol . 2020 Sep; 147(3):871-879. PMID: 32885271
Purpose: The aim of this study was to determine the diagnostic yield of multigene panel testing among patients referred with hereditary breast and ovarian cancer (HBOC). Methods: Patients who met...